Global Cell and Gene Therapy Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the Cell and Gene Therapy market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Cell and Gene Therapy business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Cell and Gene Therapy, covering the supply chain analysis, impact assessment to the Cell and Gene Therapy market size growth rate in several scenarios, and the measures to be undertaken by Cell and Gene Therapy companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Rare Diseases
Oncology
Hematology
Cardiovascular
Ophthalmology
Neurology
Other Therapeutic Classes
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Contract Research Organizations (CROs)
Hospital
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Amgen Inc.
Organogenesis Holdings Inc.
bluebird bio, Inc.
Fibrocell Science, Inc.
Human Stem Cells Institute
Dendreon Pharmaceuticals LLC.
Novartis AG
Kite Pharma, Inc.
Orchard Therapeutics plc.
Kolon TissueGene, Inc.
Vericel Corporation
ViroMed Co., Ltd.
Pfizer, Inc.
Sibiono GeneTech Co. Ltd.,
Shanghai Sunway Biotech Co., Ltd.,
Spark Therapeutics, Inc.
RENOVA THERAPEUTICS
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cell and Gene Therapy market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Cell and Gene Therapy market by identifying its various subsegments.
Focuses on the key global Cell and Gene Therapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cell and Gene Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Cell and Gene Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy Market Size 2015-2025
2.1.2 Cell and Gene Therapy Market Size CAGR by Region
2.2 Cell and Gene Therapy Segment by Type
2.2.1 Rare Diseases
2.2.2 Rare Diseases
2.2.3 Hematology
2.2.4 Cardiovascular
2.2.5 Ophthalmology
2.2.6 Neurology
2.2.7 Other Therapeutic Classes
2.3 Cell and Gene Therapy Market Size by Type
2.3.1 Global Cell and Gene Therapy Market Size Market Share by Type (2015-2020)
2.3.2 Global Cell and Gene Therapy Market Size Growth Rate by Type (2015-2020)
2.4 Cell and Gene Therapy Segment by Application
2.4.1 Pharmaceutical and Biotechnology Companies
2.4.2 Research and Academic Institutions
2.4.3 Contract Research Organizations (CROs)
2.4.4 Hospital
2.4.5 Others
2.5 Cell and Gene Therapy Market Size by Application
2.5.1 Global Cell and Gene Therapy Market Size Market Share by Application (2015-2020)
2.5.2 Global Cell and Gene Therapy Market Size Growth Rate by Application (2015-2020)
3 Global Cell and Gene Therapy by Players
3.1 Global Cell and Gene Therapy Market Size Market Share by Players
3.1.1 Global Cell and Gene Therapy Market Size by Players (2018-2020)
3.1.2 Global Cell and Gene Therapy Market Size Market Share by Players (2018-2020)
3.2 Global Cell and Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cell and Gene Therapy by Regions
4.1 Cell and Gene Therapy Market Size by Regions
4.2 Americas Cell and Gene Therapy Market Size Growth
4.3 APAC Cell and Gene Therapy Market Size Growth
4.4 Europe Cell and Gene Therapy Market Size Growth
4.5 Middle East & Africa Cell and Gene Therapy Market Size Growth
5 Americas
5.1 Americas Cell and Gene Therapy Market Size by Countries
5.2 Americas Cell and Gene Therapy Market Size by Type
5.3 Americas Cell and Gene Therapy Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Cell and Gene Therapy Market Size by Regions
6.2 APAC Cell and Gene Therapy Market Size by Type
6.3 APAC Cell and Gene Therapy Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Cell and Gene Therapy by Countries
7.2 Europe Cell and Gene Therapy Market Size by Type
7.3 Europe Cell and Gene Therapy Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Cell and Gene Therapy by Countries
8.2 Middle East & Africa Cell and Gene Therapy Market Size by Type
8.3 Middle East & Africa Cell and Gene Therapy Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Cell and Gene Therapy Market Forecast
10.1 Global Cell and Gene Therapy Market Size Forecast (2021-2025)
10.2 Global Cell and Gene Therapy Forecast by Regions
10.2.1 Global Cell and Gene Therapy Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Cell and Gene Therapy Forecast by Type
10.8 Global Cell and Gene Therapy Forecast by Application
11 Key Players Analysis
11.1 Amgen Inc.
11.1.1 Company Details
11.1.2 Cell and Gene Therapy Product Offered
11.1.3 Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Amgen Inc. News
11.2 Organogenesis Holdings Inc.
11.2.1 Company Details
11.2.2 Cell and Gene Therapy Product Offered
11.2.3 Organogenesis Holdings Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Organogenesis Holdings Inc. News
11.3 bluebird bio, Inc.
11.3.1 Company Details
11.3.2 Cell and Gene Therapy Product Offered
11.3.3 bluebird bio, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 bluebird bio, Inc. News
11.4 Fibrocell Science, Inc.
11.4.1 Company Details
11.4.2 Cell and Gene Therapy Product Offered
11.4.3 Fibrocell Science, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Fibrocell Science, Inc. News
11.5 Human Stem Cells Institute
11.5.1 Company Details
11.5.2 Cell and Gene Therapy Product Offered
11.5.3 Human Stem Cells Institute Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Human Stem Cells Institute News
11.6 Dendreon Pharmaceuticals LLC.
11.6.1 Company Details
11.6.2 Cell and Gene Therapy Product Offered
11.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Dendreon Pharmaceuticals LLC. News
11.7 Novartis AG
11.7.1 Company Details
11.7.2 Cell and Gene Therapy Product Offered
11.7.3 Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Novartis AG News
11.8 Kite Pharma, Inc.
11.8.1 Company Details
11.8.2 Cell and Gene Therapy Product Offered
11.8.3 Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Kite Pharma, Inc. News
11.9 Orchard Therapeutics plc.
11.9.1 Company Details
11.9.2 Cell and Gene Therapy Product Offered
11.9.3 Orchard Therapeutics plc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Orchard Therapeutics plc. News
11.10 Kolon TissueGene, Inc.
11.10.1 Company Details
11.10.2 Cell and Gene Therapy Product Offered
11.10.3 Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Kolon TissueGene, Inc. News
11.11 Vericel Corporation
11.12 ViroMed Co., Ltd.
11.13 Pfizer, Inc.
11.14 Sibiono GeneTech Co. Ltd.,
11.15 Shanghai Sunway Biotech Co., Ltd.,
11.16 Spark Therapeutics, Inc.
11.17 RENOVA THERAPEUTICS
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Cell and Gene Therapy Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Rare Diseases
Table 5. Major Players of Oncology
Table 6. Major Players of Hematology
Table 7. Major Players of Cardiovascular
Table 8. Major Players of Ophthalmology
Table 9. Major Players of Neurology
Table 10. Major Players of Other Therapeutic Classes
Table 11. Cell and Gene Therapy Market Size by Type (2014-2019) ($ Millions)
Table 12. Global Cell and Gene Therapy Market Size Market Share by Type (2015-2020)
Table 13. Global Cell and Gene Therapy Market Size by Application (2015-2020) ($ Millions)
Table 14. Global Cell and Gene Therapy Market Size Market Share by Application (2015-2020)
Table 15. Global Cell and Gene Therapy Revenue by Players (2018-2020) ($ Millions)
Table 16. Global Cell and Gene Therapy Revenue Market Share by Players (2018-2020)
Table 17. Global Cell and Gene Therapy Key Players Head office and Products Offered
Table 18. Cell and Gene Therapy Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Cell and Gene Therapy Market Size by Regions 2015-2020 ($ Millions)
Table 22. Global Cell and Gene Therapy Market Size Market Share by Regions 2015-2020
Table 23. Americas Cell and Gene Therapy Market Size by Countries (2015-2020) ($ Millions)
Table 24. Americas Cell and Gene Therapy Market Size Market Share by Countries (2015-2020)
Table 25. Americas Cell and Gene Therapy Market Size by Type (2015-2020) ($ Millions)
Table 26. Americas Cell and Gene Therapy Market Size Market Share by Type (2015-2020)
Table 27. Americas Cell and Gene Therapy Market Size by Application (2015-2020) ($ Millions)
Table 28. Americas Cell and Gene Therapy Market Size Market Share by Application (2015-2020)
Table 29. APAC Cell and Gene Therapy Market Size by Regions (2015-2020) ($ Millions)
Table 30. APAC Cell and Gene Therapy Market Size Market Share by Regions (2015-2020)
Table 31. APAC Cell and Gene Therapy Market Size by Type (2015-2020) ($ Millions)
Table 32. APAC Cell and Gene Therapy Market Size Market Share by Type (2015-2020)
Table 33. APAC Cell and Gene Therapy Market Size by Application (2015-2020) ($ Millions)
Table 34. APAC Cell and Gene Therapy Market Size Market Share by Application (2015-2020)
Table 35. Europe Cell and Gene Therapy Market Size by Countries (2015-2020) ($ Millions)
Table 36. Europe Cell and Gene Therapy Market Size Market Share by Countries (2015-2020)
Table 37. Europe Cell and Gene Therapy Market Size by Type (2015-2020) ($ Millions)
Table 38. Europe Cell and Gene Therapy Market Size Market Share by Type (2015-2020)
Table 39. Europe Cell and Gene Therapy Market Size by Application (2015-2020) ($ Millions)
Table 40. Europe Cell and Gene Therapy Market Size Market Share by Application (2015-2020)
Table 41. Middle East & Africa Cell and Gene Therapy Market Size by Countries (2015-2020) ($ Millions)
Table 42. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Countries (2015-2020)
Table 43. Middle East & Africa Cell and Gene Therapy Market Size by Type (2015-2020) ($ Millions)
Table 44. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Type (2015-2020)
Table 45. Middle East & Africa Cell and Gene Therapy Market Size by Application (2015-2020) ($ Millions)
Table 46. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Application (2015-2020)
Table 47. Key and Potential Regions of Cell and Gene Therapy
Table 48. Key Application and Potential Industries of Cell and Gene Therapy
Table 49. Key Challenges of Cell and Gene Therapy
Table 50. Key Trends of Cell and Gene Therapy
Table 51. Global Cell and Gene Therapy Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 52. Global Cell and Gene Therapy Market Size Market Share Forecast by Regions
Table 53. Global Cell and Gene Therapy Market Size Forecast by Type (2021-2025) ($ Millions)
Table 54. Global Cell and Gene Therapy Market Size Market Share Forecast by Type (2021-2025)
Table 55. Global Cell and Gene Therapy Market Size Forecast by Application (2021-2025) ($ Millions)
Table 56. Global Cell and Gene Therapy Market Size Market Share Forecast by Application (2021-2025)
Table 57. Amgen Inc. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 58. Amgen Inc. Cell and Gene Therapy Product Offered
Table 59. Amgen Inc. Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 60. Amgen Inc. Main Business
Table 61. Amgen Inc. Latest Developments
Table 62. Organogenesis Holdings Inc. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 63. Organogenesis Holdings Inc. Cell and Gene Therapy Product Offered
Table 64. Organogenesis Holdings Inc. Main Business
Table 65. Organogenesis Holdings Inc. Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 66. Organogenesis Holdings Inc. Latest Developments
Table 67. bluebird bio, Inc. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 68. bluebird bio, Inc. Cell and Gene Therapy Product Offered
Table 69. bluebird bio, Inc. Main Business
Table 70. bluebird bio, Inc. Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 71. bluebird bio, Inc. Latest Developments
Table 72. Fibrocell Science, Inc. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 73. Fibrocell Science, Inc. Cell and Gene Therapy Product Offered
Table 74. Fibrocell Science, Inc. Main Business
Table 75. Fibrocell Science, Inc. Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 76. Fibrocell Science, Inc. Latest Developments
Table 77. Human Stem Cells Institute Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 78. Human Stem Cells Institute Cell and Gene Therapy Product Offered
Table 79. Human Stem Cells Institute Main Business
Table 80. Human Stem Cells Institute Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 81. Human Stem Cells Institute Latest Developments
Table 82. Dendreon Pharmaceuticals LLC. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 83. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product Offered
Table 84. Dendreon Pharmaceuticals LLC. Main Business
Table 85. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 86. Dendreon Pharmaceuticals LLC. Latest Developments
Table 87. Novartis AG Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 88. Novartis AG Cell and Gene Therapy Product Offered
Table 89. Novartis AG Main Business
Table 90. Novartis AG Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 91. Novartis AG Latest Developments
Table 92. Kite Pharma, Inc. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 93. Kite Pharma, Inc. Cell and Gene Therapy Product Offered
Table 94. Kite Pharma, Inc. Main Business
Table 95. Kite Pharma, Inc. Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 96. Kite Pharma, Inc. Latest Developments
Table 97. Orchard Therapeutics plc. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 98. Orchard Therapeutics plc. Cell and Gene Therapy Product Offered
Table 99. Orchard Therapeutics plc. Main Business
Table 100. Orchard Therapeutics plc. Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 101. Orchard Therapeutics plc. Latest Developments
Table 102. Kolon TissueGene, Inc. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 103. Kolon TissueGene, Inc. Cell and Gene Therapy Product Offered
Table 104. Kolon TissueGene, Inc. Main Business
Table 105. Kolon TissueGene, Inc. Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 106. Kolon TissueGene, Inc. Latest Developments
Table 107. Vericel Corporation Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 108. ViroMed Co., Ltd. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 109. Pfizer, Inc. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 110. Sibiono GeneTech Co. Ltd., Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 111. Shanghai Sunway Biotech Co., Ltd., Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 112. Spark Therapeutics, Inc. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 113. RENOVA THERAPEUTICS Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
List of Figures
Figure 1. Cell and Gene Therapy Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Cell and Gene Therapy Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Cell and Gene Therapy Market Size Market Share by Type (2015-2020)
Figure 5. Global Rare Diseases Market Size Growth Rate
Figure 6. Global Oncology Market Size Growth Rate
Figure 7. Global Hematology Market Size Growth Rate
Figure 8. Global Cardiovascular Market Size Growth Rate
Figure 9. Global Ophthalmology Market Size Growth Rate
Figure 10. Global Neurology Market Size Growth Rate
Figure 11. Global Other Therapeutic Classes Market Size Growth Rate
Figure 12. Cell and Gene Therapy in Pharmaceutical and Biotechnology Companies
Figure 13. Global Cell and Gene Therapy Market: Pharmaceutical and Biotechnology Companies (2015-2020) ($ Millions)
Figure 14. Cell and Gene Therapy in Research and Academic Institutions
Figure 15. Global Cell and Gene Therapy Market: Research and Academic Institutions (2015-2020) ($ Millions)
Figure 16. Cell and Gene Therapy in Contract Research Organizations (CROs)
Figure 17. Global Cell and Gene Therapy Market: Contract Research Organizations (CROs) (2015-2020) ($ Millions)
Figure 18. Global Contract Research Organizations (CROs) YoY Growth ($ Millions)
Figure 19. Cell and Gene Therapy in Hospital
Figure 20. Global Cell and Gene Therapy Market: Hospital (2015-2020) ($ Millions)
Figure 21. Global Hospital YoY Growth ($ Millions)
Figure 22. Cell and Gene Therapy in Others
Figure 23. Global Cell and Gene Therapy Market: Others (2015-2020) ($ Millions)
Figure 24. Global Others YoY Growth ($ Millions)
Figure 25. Global Cell and Gene Therapy Market Size Market Share by Application in 2019
Figure 26. Global Cell and Gene Therapy Market Size Market Share by Regions 2015-2020
Figure 27. Americas Cell and Gene Therapy Market Size 2015-2020 ($ Millions)
Figure 28. APAC Cell and Gene Therapy Market Size 2015-2020 ($ Millions)
Figure 29. Europe Cell and Gene Therapy Market Size 2015-2020 ($ Millions)
Figure 30. Middle East & Africa Cell and Gene Therapy Market Size 2015-2020 ($ Millions)
Figure 31. Americas Cell and Gene Therapy Market Size Market Share by Countries in 2019
Figure 32. Americas Cell and Gene Therapy Market Size Market Share by Type in 2019
Figure 33. Americas Cell and Gene Therapy Market Size Market Share by Application in 2019
Figure 34. United States Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 35. Canada Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 36. Mexico Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 37. APAC Cell and Gene Therapy Market Size Market Share by Regions in 2019
Figure 38. APAC Cell and Gene Therapy Market Size Market Share by Type in 2019
Figure 39. APAC Cell and Gene Therapy Market Size Market Share by Application in 2019
Figure 40. China Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 41. Japan Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 42. Korea Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 43. Southeast Asia Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 44. India Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 45. Australia Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 46. Europe Cell and Gene Therapy Market Size Market Share by Countries in 2019
Figure 47. Europe Cell and Gene Therapy Market Size Market Share by Type in 2019
Figure 48. Europe Cell and Gene Therapy Market Size Market Share by Application in 2019
Figure 49. Germany Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 50. France Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 51. UK Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 52. Italy Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 53. Russia Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 54. Spain Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 55. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Countries in 2019
Figure 56. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Type in 2019
Figure 57. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Application in 2019
Figure 58. Egypt Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 59. South Africa Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 60. Israel Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 61. Turkey Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 62. GCC Countries Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 63. Global Cell and Gene Therapy arket Size Forecast (2021-2025) ($ Millions)
Figure 64. Americas Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 65. APAC Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 66. Europe Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 67. Middle East & Africa Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 68. United States Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 69. Canada Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 70. Mexico Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 71. Brazil Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 72. China Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 73. Japan Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 74. Korea Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 75. Southeast Asia Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 76. India Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 77. Australia Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 78. Germany Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 79. France Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 80. UK Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 81. Italy Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 82. Russia Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 83. Spain Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 84. Egypt Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 85. South Africa Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 86. Israel Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 87. Turkey Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 88. GCC Countries Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
